DraftKings Inc vs Medtronic PLC — how do they compare? DraftKings Inc trades at $25.22 (market cap $12.05B), while Medtronic PLC trades at $90.59 (market cap $114.45B). The key difference: Medtronic PLC is far larger — about 9.5× DraftKings Inc's market cap, and Medtronic PLC pays a 3.22% dividend while DraftKings Inc pays none. Which is the better fit depends on your goals.
| DKNG | MDT | |
|---|---|---|
Market Cap | $12.05B | $114.45B |
Sector | Consumer Cyclical | Health |
52-Week High | $48.23 | $105.35 |
52-Week Low | $20.72 | $73.75 |
Enterprise Value | $12.98B | $133.19B |
Dividend Yield | — | 3.22% |
Signals from Pluang's Aura AI — not financial advice
DraftKings (DKNG) trades at $24.03, up 8.39% today, but remains under pressure with a bearish technical signal. Recent Q2 2026 earnings missed expectations, with an EPS loss of $0.14 versus a $0.02 profit forecast. Revenue grew to $6.05 billion in 2025, but net income margins are negative. Analyst consensus is bullish with a $33.86 price target, though news highlights competition from prediction markets and promotional costs.
The outlook is mixed: strong revenue growth and positive operating cash flow support long-term potential, but profitability challenges and competitive threats pose risks. Upside depends on execution in new markets and cost management, while investor sentiment is cautious amid recent earnings misses and bearish technical trends.
Medtronic (MDT) trades at $87.16, up 1.44% today, with a bullish technical signal and consistent earnings beats. The company reported Q1 2026 EPS of $1.55, exceeding expectations, and maintains solid fundamentals with a 13.2% net income margin and $33.54B in revenue for 2025. Recent news highlights growth in cardiac ablation and the Hugo robotic platform, with management guiding for 11.75% organic revenue growth in Q1 2027.
The outlook is positive, supported by analyst consensus of a $98.75 price target and 60% buy ratings. Key opportunities include dividend stability and innovation in medical technology, while risks involve rising debt levels and competitive pressures. The stock's current valuation at a P/E of 23.37 offers moderate upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →